Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.

Strategic Device Partnership Allows Seelos to Use Aptar Pharma's Bidose (BDS) Liquid System Device with the SLS-002 Program (Intranasal Racemic Ketamine) Strategic Device Partnership Covers the Use of the BDS Liquid System for Intranasal Delivery of SLS... Biopharmaceuticals, Devices, Drug Delivery Seelos Therapeutics, AptarGroup, Bidose, intranasal ketamine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news